<?xml version="1.0" encoding="UTF-8"?>
<p>The WHO is also conducting a Phase III-IV SOLIDARITY trial globally and partners to compare four treatment options (including remdesivir) for hospitalized cases of severe COVID-19 illness. The study was launched on March 18, 2020, and as of April 21, 2020, over 100 nations were participating.</p>
